A novel drainage strategy using chest tube plus pleural catheter in uniportal upper lobectomy: A randomized controlled trial

被引:4
|
作者
Yang, Fu [1 ]
Wang, Xing [1 ,2 ]
Xu, Honglei [2 ]
Aramini, Beatrice [3 ]
Zhu, Yuming [2 ]
Jiang, Gening [2 ]
Fan, Jiang [1 ,2 ,4 ]
机构
[1] Shanghai Jiao Tong Univ, Dept Thorac Surg, Peoples Hosp 1, Shanghai, Peoples R China
[2] Shanghai Tongji Univ, Dept Thorac Surg, Affiliated Shanghai Pulm Hosp, Shanghai, Peoples R China
[3] Univ Bologna, GB Morgagni L Pierantoni Hosp, Div Thorac Surg, Forli, Italy
[4] Shanghai Jiao Tong Univ, Peoples Hosp 1, Dept Thorac Surg, Shanghai 200080, Peoples R China
基金
中国国家自然科学基金;
关键词
chest tube; pleural catheter; uniportal video-assisted thoracoscopic surgery; upper lobectomy; PULMONARY LOBECTOMY; SINGLE; MANAGEMENT;
D O I
10.1111/1759-7714.14759
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: In this study we explored whether one pleural catheter plus single chest tube drainage could achieve a noninferior drainage effect when compared with the traditional two chest tubes in uniportal video-assisted thoracoscopic surgery (VATS) for an upper pulmonary lobectomy. Methods: Patients that underwent an upper pulmonary lobectomy from January to November 2020 were enrolled in this single-center, randomized, open-label, noninferiority trial. Prior to closure, patients were randomized to an intervention group who received an improved drainage strategy involving one pleural catheter with one chest tube (24 Fr), while traditional double chest tube drainage was applied for the control group. Results: A total of 390 patients entered the study, although 190 were excluded for changing nonuniportal surgical approaches or opting for nonlobectomy resections. Finally, 200 patients were randomized (100 in the intervention group and 100 in the control group). The baseline demographic and clinical characteristics were comparable between the groups. The incidence of pneumothorax in the intervention and control groups was similar on postoperative Day 1 (noninferiority, 10% vs. 13%, p = 0.658). In addition, there were no significant differences in secondary outcomes such as incidence of pneumothorax by Day 30, postoperative chest tube/pleural catheter removal time, amount of drainage on Day 1, total amount of drainage after operation, or postoperative hospitalization. A significantly lower pain score was observed in the intervention group (3.33 +/- 0.68 vs. 3.68 +/- 0.94, p = 0.003). Conclusions: The new strategy is noninferior to double chest tube drainage after an upper pulmonary lobectomy offers superior pain control, and is recommended for an upper lobectomy by uniportal VATS.
引用
收藏
页码:399 / 406
页数:8
相关论文
共 36 条
  • [31] Verification study on the catheterization of an upper arm vein using the new long peripheral intravenous catheter to reduce catheter failure incidence: A randomized controlled trial
    Murayama, Ryoko
    Abe-Doi, Mari
    Masamoto, Yosuke
    Kashiwabara, Kosuke
    Komiyama, Chieko
    Sanada, Hiromi
    Kurokawa, Mineo
    DRUG DISCOVERIES AND THERAPEUTICS, 2023, 17 (01): : 52 - 59
  • [32] Phase II study of efficacy of bevacizumab plus chemotherapy in management of malignant pleural effusion in non-squamous non-small cell lung cancer patients with malignant pleural effusion (MPE) unsuccessfully controlled by tube drainage or pleurodesis (NEJ-13-2 trial)
    Noro, R.
    Kobayashi, K.
    Usuki, J.
    Hosomi, Y.
    Nishitsuji, M.
    Okamoto, H.
    Ando, M.
    Hino, M.
    Hagiwara, K.
    Miyanaga, A.
    Seike, M.
    Kubota, K.
    Gemma, A.
    ANNALS OF ONCOLOGY, 2017, 28
  • [33] Efficacy and safety of palliative endobiliary radiofrequency ablation using a novel temperature-controlled catheter for malignant biliary stricture: a single-center prospective randomized phase II TRIAL
    Kang, Huapyong
    Chung, Moon Jae
    Cho, In Rae
    Jo, Jung Hyun
    Lee, Hee Seung
    Park, Jeong Youp
    Park, Seung Woo
    Song, Si Young
    Bang, Seungmin
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2021, 35 (01): : 63 - 73
  • [34] Efficacy and safety of palliative endobiliary radiofrequency ablation using a novel temperature-controlled catheter for malignant biliary stricture: a single-center prospective randomized phase II TRIAL
    Huapyong Kang
    Moon Jae Chung
    In Rae Cho
    Jung Hyun Jo
    Hee Seung Lee
    Jeong Youp Park
    Seung Woo Park
    Si Young Song
    Seungmin Bang
    Surgical Endoscopy, 2021, 35 : 63 - 73
  • [35] RANDOMIZED CONTROLLED TRIAL COMPARING THE BOWEL CLEANSING EFFICACY OF NOVEL 1 LITRE POLYETHYLENE GLYCOL plus ASCORBATE NER1006 VERSUS HIGH-VOLUME POLYETHYLENE GLYCOL USING A SPLIT DOSING REGIMEN
    Repici, Alessandro
    Spada, Cristiano
    Cannizzaro, Renato
    Di Leo, Milena
    Traina, Mario
    Buda, Andrea
    Occhipinti, Pietro
    Manno, Mauro
    Fuccio, Lorenzo
    Maselli, Roberta
    Galtieri, Piera Alessia
    Cesaro, Paola
    Spadaccini, Marco
    Lamonaca, Laura
    Minelli, Luigi
    Granata, Antonino
    Antonelli, Giulio
    Maiero, Stefania
    Guarnieri, Giovanni
    Amata, Michele
    Badalamenti, Matteo
    Lorenzetti, Roberto
    Zullo, Angelo
    Pellegatta, Gaia
    Fugazza, Alessandro
    Carrara, Silvia
    Hassan, Cesare
    GASTROINTESTINAL ENDOSCOPY, 2020, 91 (06) : AB460 - AB461
  • [36] Phase II study of efficacy of bevacizumab plus chemotherapy in management of malignant pleural effusion (MPE) in non-squamous non-small cell lung cancer (NSCLC) patients with MPE unsuccessfully controlled by tube drainage or pleurodesis (North East Japan Study Group Trial NEJ-013B-2).
    Noro, Rintaro
    Kobayashi, Kunihiko
    Usuki, Jiro
    Hosomi, Yukio
    Nishitsuji, Masaru
    Okamoto, Hiroaki
    Hino, Mitsunori
    Hagiwara, Koichi
    Miyanaga, Akihiko
    Seike, Masahiro
    Kubota, Kaoru
    Gemma, Akihiko
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35